Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 206 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implantable Defibrillator Clear all

Conditions: Cardiomyopathy, Dilated, Arrhythmia, Anger, Stress
Interventions: Cognitive Behavioral Stress Management (CBSM), Patient Education; Behavioral · Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years to 85 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases, Implantable Cardioverter Defibrillator
Interventions: Azimilide Dihydrochloride, Placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 83
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 72 more

Conditions: Arrhythmia, Tachycardia, Ventricular, Ventricular Fibrillation
Interventions: SSR149744C; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 21 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Heart Disease, Cardiovascular Disease, Heart Failure, Arrhythmias, Cardiac
Interventions: Unpaired remote monitoring transmitter; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Sudden Cardiac Death
Interventions: Not listed
Lead sponsor: Pocono Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: East Stroudsburg, Pennsylvania

Conditions: Heart Failure, Ischemic Cardiomyopathy, ICD Patients
Interventions: 18F-metaFluorobenzylguanidine, Rubidium-82; Drug
Lead sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC); Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cardiac Pacing
Interventions: Cardiac Waveform Generator; Device
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ventricular Tachycardia
Interventions: amiodarone, sotalol, Biosense Webster's NAVI-STAR Thermo-Cool; Drug · Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 5
States / cities: Baltimore, Maryland • Durham, North Carolina • Columbus, Ohio + 2 more

Conditions: Ventricular Tachycardia
Interventions: clonidine, metoprolol; Drug
Lead sponsor: James Martins; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Pacemaker, Implantable Cardioverter-Defibrillators
Interventions: Questionnaires, Phone Interviews, Educational Packet; Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Implantable Defibrillator User
Interventions: Ellipse VR ICD and Durata/Optisure lead; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 26
States / cities: Phoenix, Arizona • Bakersfield, California • La Jolla, California + 22 more

Conditions: Arrhythmia
Interventions: Azimilide Dihydrochloride, placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 633 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 78
States / cities: Mobile, Alabama • Mesa, Arizona • Little Rock, Arkansas + 67 more

Conditions: Congenital Disorders
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: Up to 21 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1998
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Lead Extraction Procedures
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Atrial Fibrillation, Stroke
Interventions: Apixaban, aspirin; Drug
Lead sponsor: Population Health Research Institute; Other
Eligibility: 55 Years and older
Enrollment: 4,012 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 23
States / cities: Mesa, Arizona • Little Rock, Arkansas • Larkspur, California + 20 more

Conditions: Cardiomyopathies
Interventions: Clinical Reminder; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Palo Alto, California • Stanford, California

Conditions: Systolic Heart Failure, Sudden Cardiac Death
Interventions: ICD Decision Aid Toolkit; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Implantable Cardioverter-defibrillators (ICDs)
Interventions: Pre-visit timing of receipt of the ICDs implantation decision aid, Post-visit timing of receipt of the ICDs implantation decision aid; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Arrhythmia Prophylaxis, Ventricular Arrhythmia
Interventions: Celivarone, Amiodarone, Matching placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 21 Years and older
Enrollment: 486 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 37
States / cities: Huntsville, Alabama • Mobile, Alabama • Mesa, Arizona + 33 more

Conditions: Heart Failure, Cardiomyopathy, Cardiac Arrhythmia
Interventions: QLV interval measurement; Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Ventricular Tachycardia, Ventricular Fibrillation, Atrial Fibrillation, Supraventricular Tachycardia
Interventions: Dual Chamber ICD, Single Chamber ICD; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Patient Safety
Interventions: Academic detailing and audit and feedback intervention; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Heart Failure, Obesity
Interventions: Body Composition Analysis InBody Scale; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ventricular Arrhythmia, Implantable Cardioverter Defibrillator
Interventions: Quality of Life Therapy (QOLT), Heart Healthy Education (HHE); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Charleston, South Carolina

Search by objective public record fields.

Mental Stress Reduction in Defibrillator Patients

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS

Remote Interrogation in Rural Emergency Departments

Study of Paced QRS Duration as a Marker of Sudden Cardiac Death

18F-mFBG Imaging for Myocardial Sympathetic Innervation

Cardiac Anodal Biphasic Pacing

Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator

Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing

Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs)

A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study

Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators

Automated Cardioverter Defibrillator in Children

Pacemaker and Defibrillator Lead Extraction Registry

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

Implantable Cardioverter-Defibrillator Use in the VA System

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

Syngery-Evaluating the Impact of Decision Aid

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.

The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock

An Intervention to Impact Cardiovascular Implantable Electronic Device Lead Models Implanted in Veterans

Safety of Body Composition Analysis in Heart Failure Patients With Implantable Cardioverter Defibrillators (ICDs)

Positive Therapy for Autonomic Function & Mood in ICD Patients